Research & Impact
At Medicinal Technologies, every discovery is driven by purpose. From pioneering molecular equations to real-world therapeutic breakthroughs, our science is changing lives — one patient at a time.
Intellectual Property
Patents & Innovation Portfolio
Our intellectual property reflects years of rigorous scientific inquiry and breakthrough discoveries at the intersection of biomedicine and biotechnology.
MEnera's formula patent app# 19/545,021 & CIP for bioengineering #19/777,987.
* Additional patent information available upon request.
Reference numbers shown for identification purposes.
Scientific Literature
Publications & Media Coverage
Our research has been recognized across leading scientific and media platforms, validating the significance of our innovations.
Key Achievements
Research Highlights & Milestones
From foundational science to commercial-ready biologics, here are the milestones that define our journey.
The Tejeda Equation
Dr. Tejeda's groundbreaking equation describes the molecular mechanism of Endometriosis development, offering new diagnostic insight and reshaping treatment pathways across gynecological biomedicine.
Active Clinical Pipeline
We are advancing a pipeline of small cell biologics with potential over-the-counter impact — bridging laboratory breakthroughs with regulatory-ready therapeutic solutions.
Multi-Specialty R&D Focus
Our active research spans Oncology, Ophthalmology, and Gynecology — targeting complex disorders at their biological root with precision formulations developed in-house.
U.S.-Based Manufacturing
All research, development, and manufacturing operations are conducted entirely within the United States — ensuring quality, compliance, and accountability at every stage.
National Recognition
Medicinal Technologies has been recognized by FindATopDoc and featured across MSN, The Science Times, Science World Report, and the NY Weekly for scientific contributions.
Collaborative Science
We actively partner with academic institutions, clinical researchers, and industry collaborators to advance biopharmaceutical solutions that shape the future of personalized healthcare.
Notable Milestones
Medicinal Technologies founded with a mission to advance science-backed biopharmaceutical therapies.
Featured in The Science Times, NY Weekly, and additional national publications for research contributions.
The Tejeda Equation published — a breakthrough in understanding Endometriosis at the molecular level. Recognized by FindATopDoc.
Expanded R&D into Ophthalmology and Oncology; MEnera product line developed for gynecological support.
Active clinical pipeline advancing toward regulatory review; continued U.S. manufacturing expansion.
Get Involved
Ready to Be Part of the Impact?
Whether you're a patient, researcher, or supporter — there's a place for you in our mission to advance health through science.